NCT06841575 Advancing Pediatric Retinal Imaging With Auto-aligned OCT
| NCT ID | NCT06841575 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Duke University |
| Condition | Eye Diseases |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2026-03-23 |
| Primary Completion | 2027-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2026-03-23 with a primary completion date of 2027-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of the current study is to conduct a pilot study to test a new version of the handheld OCT device capable of auto-alignment to image the retina in adult volunteers, and adult and pediatric patients in clinic.
Eligibility Criteria
Inclusion Criteria: * Group 1: Healthy adult volunteers * Subject is able and willing to consent to study participation * Subject is more than 18 years of age * Healthy adult volunteers without known ocular issues other than refractive error * Group 2: Adult patients in ophthalmology clinics * Health care provider, knowledgeable of protocol, agrees that study personnel could contact the subject * Subject is able and willing to consent to study participation * Subject is more than 18 years of age and is a patient in the Duke Eye Center ophthalmology clinics * Group 3: Pediatric participants in ophthalmology clinics * Health care provider, knowledgeable of protocol, agrees that study personnel could contact the parent/legal guardian * Parent/legal guardian is able and willing to consent to study participation * Pediatric patient less than 18 years of age in Duke Eye Center ophthalmology clinics or undergoing clinically-indicated examination under anesthesia at Duke Eye Center Exclusion Criteria: * Group 1: Healthy adult volunteers * Students or employees under direct supervision of the investigators * Subjects with prior problems with pupil dilation * Pregnant woman if receiving dilating drops * Group 2: Adult patients in ophthalmology clinics * Participant has a health or eye condition that preclude eye examination or retinal imaging (such as corneal opacity or cataract) * Group 3: Pediatric participants in ophthalmology clinics * Parent/legal guardian unwilling or unable to provide consent * Participant has a health or eye condition that preclude eye examination or retinal imaging (such as corneal opacity or cataract)
Contact & Investigator
Xi Chen, MD, PhD
PRINCIPAL INVESTIGATOR
Duke University
Frequently Asked Questions
Who can join the NCT06841575 clinical trial?
This trial is open to participants of all sexes, aged 1 Month or older, studying Eye Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06841575 currently recruiting?
Yes, NCT06841575 is actively recruiting participants. Contact the research team at xi2.chen@duke.edu for enrollment information.
Where is the NCT06841575 trial being conducted?
This trial is being conducted at Durham, United States.
Who is sponsoring the NCT06841575 clinical trial?
NCT06841575 is sponsored by Duke University. The principal investigator is Xi Chen, MD, PhD at Duke University. The trial plans to enroll 50 participants.